A&D Pharma intends to give up London Stock Exchange listing next year

Newsroom 20/12/2010 | 16:23

A&D Pharma intends to give up the listing from the London Stock Exchange. A decision in this sense will be made at the end of January, according to Mediafax newswire.

The last day of transaction with the company’s shares will be February 28, 2011. A&D Pharma has been listed at the London Stock Exchange since 2006. The company posted EUR 482.2 million in the first nine months of the year, which represented 32 percent growth on the similar period of 2009.

The main shareholder in A&D Pharma is Sograno, with a 59 percent stake, a company registered in The Netherlands. Sograno is owned by Michel Eid, Ludovic Robert, Roger Akoury and Walid Abboud. A stake of 34 percent is transactioned on the capital market and the remaining 7 percent belongs to former CEOs of the company.

Otilia Haraga


BR Magazine | Latest Issue

Download PDF or read online: October 2022 Issue | Business Review Magazine

The October 2022 issue of Business Review Magazine is now available in digital format, featuring the main cover story titled “Globalworth Successfully Addressing Market Challenges From a Position
Newsroom | 26/10/2022 | 17:53

    You will receive a download link for the latest issue of Business Review Magazine in PDF format, based on the completion of the form below.

    I agree with the Privacy policy of business-review.eu
    I agree with the storage and handling of my data by business-review.eu
    Advertisement Advertisement
    Close ×

    We use cookies for keeping our website reliable and secure, personalising content and ads, providing social media features and to analyse how our website is used.

    Accept & continue